These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38369020)

  • 21. Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.
    Ternik R; Liu F; Bartlett JA; Khong YM; Thiam Tan DC; Dixit T; Wang S; Galella EA; Gao Z; Klein S
    Int J Pharm; 2018 Feb; 536(2):570-581. PubMed ID: 28844897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations.
    van der Merwe SM; Verhoef JC; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Jan; 57(1):85-91. PubMed ID: 14729083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Solid Oral Dosage Form Characteristics on Swallowability, Visual Perception, and Handling in Older Adults.
    Hummler H; Page S; Stillhart C; Meilicke L; Grimm M; Mannaa M; Gollasch M; Weitschies W
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innovations in Chewable Formulations: The Novelty and Applications of 3D Printing in Drug Product Design.
    Rodríguez-Pombo L; Awad A; Basit AW; Alvarez-Lorenzo C; Goyanes A
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensory aspects of acceptability of bitter-flavoured 7.5 mm film-coated tablets in adults, preschool and school children.
    Hofmanová JK; Mason J; Batchelor HK
    Int J Pharm; 2020 Jul; 585():119511. PubMed ID: 32522503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues.
    Belissa E; Vallet T; Laribe-Caget S; Chevallier A; Chedhomme FX; Abdallah F; Bachalat N; Belbachir SA; Boulaich I; Bloch V; Delahaye A; Depoisson M; Wojcicki AD; Gibaud S; Grancher AS; Guinot C; Lachuer C; Lechowski L; Leglise P; Mahiou A; Meaume S; Michel C; Michelon H; Orven Y; Perquy I; Piccoli M; Rabus M; Ribemont AC; Rwabihama JP; Trouvin JH; Ruiz F; Boudy V
    BMC Geriatr; 2019 Dec; 19(1):344. PubMed ID: 31810442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People.
    Bracken L; Habashy R; McDonough E; Wilson F; Shakeshaft J; Ohia U; Garcia-Sorribes T; Isreb A; Alhnan MA; Peak M
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-appropriate solid oral formulations for pediatric applications with a focus on multiparticulates and minitablets: Summary of September 2019 EuPFI workshop.
    Harris D; Hermans E; Klein S; Wagner-Hattler L; Walsh J
    Eur J Pharm Biopharm; 2020 Aug; 153():222-225. PubMed ID: 32580052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of caregivers of Nigerian children less than 6 years of age to determine the experience and perception of acceptability of oral solid dosage forms.
    Orubu S; Okwelogu C; Opanuga O; Tuleu C
    Int J Pharm; 2018 Feb; 536(2):582-589. PubMed ID: 29100913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-Appropriate Pediatric Dosage Forms in Japan: Insights into End-User Perceptions From an Observational Cross-Sectional Survey Assessing the Acceptability of Oral Formulation.
    Saito J; Akabane M; Komura M; Nakamura H; Ishikawa Y
    Ther Innov Regul Sci; 2019 Jul; 53(4):455-471. PubMed ID: 30157669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of emerging technologies enabling improved solid oral dosage form manufacturing and processing.
    Sohail Arshad M; Zafar S; Yousef B; Alyassin Y; Ali R; AlAsiri A; Chang MW; Ahmad Z; Ali Elkordy A; Faheem A; Pitt K
    Adv Drug Deliv Rev; 2021 Nov; 178():113840. PubMed ID: 34147533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive review on oral disintegrating films.
    Nagaraju T; Gowthami R; Rajashekar M; Sandeep S; Mallesham M; Sathish D; Kumar YS
    Curr Drug Deliv; 2013 Feb; 10(1):96-108. PubMed ID: 22920576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
    Klingmann V; Hinder M; Langenickel TH; Chen F; Khder Y; Breitkreutz J; Bosse HM
    Arch Dis Child; 2023 Sep; 108(9):730-735. PubMed ID: 36963813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptability of different oral formulations in infants and preschool children.
    van Riet-Nales DA; de Neef BJ; Schobben AF; Ferreira JA; Egberts TC; Rademaker CM
    Arch Dis Child; 2013 Sep; 98(9):725-31. PubMed ID: 23853004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Cellulose Nanofibers on the Manufacturing of Mini-Tablets by Direct Powder Compression.
    Nakamura S; Nakura M; Sakamoto T
    Chem Pharm Bull (Tokyo); 2022; 70(9):628-636. PubMed ID: 36047234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Nanotechnology in Taste Masking: Recent Updates.
    Vishvakarma V; Kaur M; Nagpal M; Arora S
    Curr Drug Res Rev; 2023; 15(1):1-14. PubMed ID: 35619251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-Analytical Framework to Assess the In Vitro Swallowability of Solid Oral Dosage Forms Targeting Patient Acceptability and Adherence.
    Ershad AL; Rajabi-Siahboomi A; Missaghi S; Kirby D; Mohammed AR
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33808875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.